Furthermore, in mantle cell lymphoma, SB-225002 overcame drug resistance by inhibiting the activation of Akt, STAT3, and p38 signaling pathways and reprogramming lymphoma-associated macrophages (Sun et al., 2025). The gene discussed is STAT3; the disease is mantle cell lymphoma.